The study is ongoing at multiple sites including the Animal Referral Hospital in Homebush, NSW and Queensland Veterinary Specialists in Brisbane, QLD. The study is aiming to recruit up to 10 dogs with final results expected approximately Q3 2017.
Should start to get interting shortly.
- Forums
- ASX - By Stock
- Ann: Phase II trial prelim results demonstrate clinical benefit
The study is ongoing at multiple sites including the Animal...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $93.42M |
Open | High | Low | Value | Volume |
19.0¢ | 19.5¢ | 19.0¢ | $41.04K | 216.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 36359 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 19561 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 36359 | 0.190 |
15 | 844962 | 0.185 |
8 | 336753 | 0.180 |
4 | 120797 | 0.175 |
5 | 159661 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 19561 | 2 |
0.200 | 114894 | 6 |
0.205 | 109808 | 2 |
0.210 | 107676 | 2 |
0.215 | 100000 | 1 |
Last trade - 12.34pm 13/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online